Searching For The Cure Feature Documentary Now Listed on IMDb

Visioneering Entertainment LLC is filming their feature documentary, "Searching for the Cure," following patients using marijuana as an alternative for fighting cancer. - April 19, 2017 - Searching For The Cure Foundation

The Children’s Cancer Foundation, Inc. (CCF) Highlights Critical Pediatric Cancer Treatment Research at 2nd Annual Research Symposium on June 7, 2017

The Children’s Cancer Foundation, Inc. (CCF) highlights critical pediatric cancer treatment research at 2nd Annual Research Symposium on June 7, 2017 Each year in the U.S., more than 50,000 children are diagnosed with cancer, and approximately 1000 will die. While the survival rate has... - April 16, 2017 - The Children's Cancer Foundation, Inc.

MiTeGen Opens NANUQ Access Facility

MiTeGen LLC, a provider of innovative consumables and equipment for protein crystallization and single crystal X-ray, announced the opening of the NANUQ Access Facility (NAF) which provides scientists with day-use access to MiTeGen’s revolutionary automated high-speed cryocooling device (NANUQ). - April 12, 2017 - MiTeGen, LLC

Hearing Implant Device Takes Out the Top Prize in MedTech’s Got Talent

Hemideina, a Victorian startup commercialising an internalised hearing device, has taken out the top prize in STC Australia’s 3rd cohort of MedTech’s Got Talent. - April 12, 2017 - STC

Searching For The Cure Foundation Moves Forward with Axcel International Proposal for Sponsorship

A partnership providing a solid web presence infrastructure robust enough for the various cancer patient programs, cannabis cancer research, and services currently being developed. - April 07, 2017 - Searching For The Cure Foundation

Tactiva Therapeutics Reports Data Highlighting a Novel Dual CD4/CD8 T Cell Receptor with Potential for Use Against a Broad Range of Cancers

Tactiva Therapeutics today reported on its unique, dual enhanced adoptive cell therapy (DEACT) platform, incorporating its proprietary, engineered CD4/CD8 T cell receptors (TCR) with potential broad utility in cancer immunotherapy, including melanoma and ovarian cancer. A late breaking abstract... - April 05, 2017 - Tactiva Therapeutics

Axcel International Submits Corporate Partnership with Searching For The Cure Foundation

This non-monetary partnership insures a solid infrastructure for the various cancer patient programs, cannabis cancer research, and services currently in development. - March 31, 2017 - Searching For The Cure Foundation

Latest Research on Myopia (Nearsightedness) Conducted at MIT and Multivision Research Shows How to Prevent It

The latest research on myopia published online this month shows how to prevent nearsightedness. It has been confirmed that myopia can be prevented by correcting the hyperopia of a child at risk of becoming myopic. Medina, A. Prevention of myopia by partial correction of hyperopia: a twins study. Int Ophthalmol (2017). doi:10.1007/s10792-017-0493-7 - March 31, 2017 - Antonio Medina

Cyrex Laboratories Unveils Array 22 for Unprecedented Accuracy in Assessing SIBO

Cyrex Laboratories, a clinical laboratory specializing in functional immunology and autoimmune reactivity, is leading the charge with their new Array 22- Irritable Bowel/SIBO Screen. - March 24, 2017 - Cyrex Laboratories

NCHS President and CEO, Irma Cota, Announces Retirement

NCHS President and CEO, Irma Cota, Announces Retirement

After 20 rewarding years, Irma Cota will be retiring from NCHS but her legacy to serve will always remain. - March 22, 2017 - NCHS

AAA Test Lab Certified by DOD for Test and Authentication of Military Electronic Components

AAA Test Lab has been approved to authenticate electronic components for the DOD. - March 18, 2017 - AAA Test Lab Inc.

ISTH 2017 Congress on Track to Break Records in Field for Attendance and New Innovations

Global Scientific Meeting Slated to be World’s Largest Gathering of Experts in Thrombosis and Hemostasis. - March 15, 2017 - International Society on Thrombosis and Haemostasis (ISTH)

ProPath Receives Accreditation for Dermatopathology Fellowship Program Through 2027

ProPath maintains the only free-standing dermatopathology fellowship training program in the US. - March 15, 2017 - ProPath

MR Solutions Introduces 9.4T Preclinical MRI Imaging Solution to Cardiovascular Sector

MR Solutions’ new 9.4 tesla cryogen free preclinical scanners created great interest from cardiologists at the 20th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR). - March 08, 2017 - MR Solutions

New Study Links Weed-Killer Glyphosate with Autism

A new study has been published in a peer-reviewed journal about the links between the weed-killer glyphosate (RoundUpTM) and autism. The World Health Organization International Agency for Research on Cancer published a summary in March 2015 that classified glyphosate as a probable carcinogen in humans. - March 07, 2017 - The Great Plains Laboratory, Inc.

Cyrex Laboratories Adds Unique Expertise with Two New Team Members

Cyrex Laboratories continues to attract the best and brightest in immunology testing with additions of Dr. Mark Engelman and Michelle Clark. - March 03, 2017 - Cyrex Laboratories

Baebies Completes First Close on Series B Financing

Baebies Completes First Close on Series B Financing

Baebies announced today it has completed a $5 million first close on its Series B financing. - February 27, 2017 - Baebies, Inc.

Colortrieve Systems Inc. is Now a Verified Veteran Owned Small Business

The US Department of Veterans Affairs has verified Colortrieve's status as a Veteran Owned Small Business (VOSB). Colortrieve sells radiology and medical supplies to over 1000 healthcare facilities in all 50 states. As a VOSB, Colortrieve is eligible to participate in the Veterans First Contracting Program and will have an opportunity to increase its sales to VA facilities nationally. Colortrieve's products are Made in the USA by Small Business Manufacturers. - February 16, 2017 - Colortrieve Systems Inc.

Zifo RnD Solutions Ranked Number 350 Fastest Growing Technology Company on the Deloitte Technology Fast 500™ Asia Pacific 2016

Zifo RnD Solutions today announced that it ranked Number 350 on the Deloitte Technology Fast 500™ Asia Pacific 2016, a ranking of the 500 fastest growing technology companies in Asia Pacific. Rankings are based on percentage revenue growth over three years. Zifo RnD Solutions grew 146 percent... - February 02, 2017 - Zifo

Bioscience Americas Unveils New, Patient Focused Website

New website allows prospective patients to sign-up for autologous stem cell therapies at the Company's Colombia location. - January 30, 2017 - Bioscience Americas

International Society on Thrombosis and Haemostasis Launches Editor(s)-in-Chief Search for Its Flagship Journal

Call for Applications Now Open for Succeeding Editor(s)-in-Chief of the Journal of Thrombosis and Haemostasis - January 19, 2017 - International Society on Thrombosis and Haemostasis (ISTH)

Dr. Shekhar Challa Joins Bioscience Americas Board of Advisors

Dr. Shekhar Challa Joins Bioscience Americas Board of Advisors

Co-Founder of the Kansas Medical Clinic is a renowned gastroenterologist. - January 13, 2017 - Bioscience Americas

The Zoozler Venture Network is Looking for an Idea

You have a fantastic idea for a product or service but you don't know how to go about making it a reality. You know that you'll need investors but how do you get to them? That's where the Zoozler Venture Network can help. The Zoozler Venture Network will take the idea and help make it into a successful reality. - January 13, 2017 - Zoozler

Mopec Celebrates 25 Years

Twenty-five pathology professionals will be awarded for anniversary event. - January 11, 2017 - Mopec

The Morgan Leary Vaughan Fund Launches First Natural History Registry for Necrotizing Enterocolitis

The Morgan Leary Vaughan Fund (Morgan's Fund) has launched the first natural history registry for Necrotizing Enterocolitis. The research study is open to participants worldwide to advance understanding and treatments for rare disease that leads to necrosis (death) of the intestine. - January 09, 2017 - The Morgan Leary Vaughan Fund, Inc.

Prefilled Syringes Market to Grow at 3.9% Annually, Predicts Roots Analysis

Roots Analysis has announced the addition of the “Prefilled Syringes Market (4th Edition), 2017-2026” report to its list of offerings. The report provides a comprehensive analysis of the current state and the likely future evolution of the prefilled syringes market. It provides details... - January 08, 2017 - Roots Analysis

Water Expert Issues Notice Over Concerns of Arsenic in Kentucky Water Supply

Chris Myers, an authority on drinking water testing and founder of Environmental Laboratories Inc. (ELI) issued a notice of his concerns about Arsenic contamination in drinking water supplies. He has a specific concern regarding the potential contamination of area water supplies, from the Arsenic... - January 05, 2017 - Safe Home EnviroLabs

Bioscience Americas Names Addition to Its Board of Advisors

Bioscience Americas Names Addition to Its Board of Advisors

Dr. Firas M. Kara joins Board to assist with Bioscience Americas international development efforts. - January 03, 2017 - Bioscience Americas

Children's Rights in Danger: Dr. Jim Sears Speaks Up for the Babies at American Safe Sight Foundation

Children's Rights in Danger: Dr. Jim Sears Speaks Up for the Babies at American Safe Sight Foundation

Dr. Jim Sears, of The Doctors Show on CBS, knows babies. As a pediatrician known best for his family's medical practice in the charming little coastal town of San Juan Capistrano, "Dr. Jim" is loved by his littlest patients and parents alike. Dr. Jim gave the babies a voice in his keynote Speech at The American Safe Sight Foundation (ASF) on health-care caused EKC transmission to babies by ophthalmologists. - December 25, 2016 - American Safe Sight Foundation

3D Map of PC2 to Jump-Start Drug Discovery Efforts in Polycystic Kidney Disease

Scientists from the Structural Genomics Consortium (SGC) and Oxford University report a three-dimensional view of the Polycystin-2 (PC2), a protein that causes autosomal dominant polycystic kidney disease (ADPKD) when mutated, in an article published this week in Nature Structural and Molecular... - December 21, 2016 - The SGC

QPS Bio-Kinetic Names Brendon Bourg Vice President and General Manager

QPS Bio-Kinetic, one of the largest independent Phase 1 Clinical Research Organization (CRO) facilities in the country, today announces the appointment of Brendon Bourg as Vice President and General Manager. Bourg will administer and monitor all aspects of the Phase 1 facility and report to Ben Chein, President and CEO of QPS Holdings, LLC. - December 19, 2016 - QPS Bio-Kinetic

Fierce Innovation Awards: Life Sciences Edition Announce Finalists, Innovative Biochips Recognized

Fierce Innovation Awards: Life Sciences Edition Announce Finalists, Innovative Biochips Recognized

Innovative Biochips LLC has been selected as a finalist in Fierce Innovation Awards 2016 for its innovative product, Automated Yeast Aging Analysis System. - December 15, 2016 - Innovative Biochips

Europital Introduced PenThu® at the Clinical Operations in Oncology Trials Event

Europital participated at the “Clinical Operations in Oncology Trials Europe 2016” that was held the 29th and 30th of November in Amsterdam, in which PenThu® was officially introduced to all professionals attendees. - December 14, 2016 - Europital BVBA

Bioscience Americas Lauds Passage of the 21st Century Cures Act

Bioscience Americas Lauds Passage of the 21st Century Cures Act

President Obama is expected to sign this landmark bi-partisan legislation soon. - December 13, 2016 - Bioscience Americas

Stem Cells Can Successfully Treat Patients with Type 1 Diabetes

Stem Cells Can Successfully Treat Patients with Type 1 Diabetes

The Bioscience Americas science team has a 5-year, 76% remission rate treating Type 1 diabetes using a patient's own stem cells. - December 08, 2016 - Bioscience Americas

The Cardiac & Vascular Institute Research Foundation to Participate in National Institutes of Health TACT2 Research Trial

The Cardiac & Vascular Institute Research Foundation to Participate in National Institutes of Health TACT2 Research Trial

Second study will focus on benefits of removing toxic metal pollutants in patients with diabetes and a prior heart attack. - December 07, 2016 - The Cardiac & Vascular Institute

Hometown Urgent Care Supporting Local Community with Multi-Location Food Drive Through December 15

Hometown Urgent Care Continues Efforts to Support Local Community.. - December 07, 2016 - Hometown Urgent Care

New Research Explores Wearable Technology Utilization in Clinical Trials and the Role of CROs

New Report Identifies Current and Future Wearable Technology Utilization and CRO Implications with 130 Clinical Outsourcing Decision Makers. - December 01, 2016 - Life Science Strategy Group, LLC

Digital Health Startup Vitalistics Announces Public Launch

Vitalistics, a digital health startup transforming the overnight pulse oximetry and home sleep testing experience, launches today. - November 30, 2016 - Vitalistics

Zifo RnD Solutions Ranked Number 40 Fastest Growing Technology Company on the Deloitte Technology Fast 50™ India 2016

Attributes its 146% revenue growth to the Zifo team’s collective strength and commitment towards customer’s success. - November 23, 2016 - Zifo

Mount Sinai Beth Israel Receive Award from the Department of Defense to Study Gulf War Illness with electroCore’s Non-Invasive Vagus Nerve Stimulation Therapy

The Pain & Fatigue Study Center at Mount Sinai Beth Israel in New York has been awarded a United States Army Medical Research grant to conduct a study into the treatment of veterans of the 1990-1991 Gulf War who have Gulf War Illness using electroCore’s non-invasive vagus nerve... - November 17, 2016 - electroCore

Transnetyx Nears 12 Million Samples Genotyped, Gives 700 Working Years Back to Research

Transnetyx Nears 12 Million Samples Genotyped, Gives 700 Working Years Back to Research

Transnetyx, an automated genotyping company, today announced that it will reach 12 million samples processed by the end of 2016. Since it began its operations in 2004, Transnetyx has served the research of more than 600 organizations – universities, hospitals and bioscience companies –... - November 16, 2016 - Transnetyx

New Gastrointestinal Pathogen Assays Available from ALPCO

New Gastrointestinal Pathogen Assays Available from ALPCO

ALPCO is now offering a line of research assays for the investigation of common bacterial and parasitic gastrointestinal (GI) pathogens including Giardia lamblia, Cryptosporidium spp., Blastocystis hominis, Entamoeba histolytica/dispar, and Clostridium difficile. These assays can be used to... - November 15, 2016 - ALPCO

New Ultrasensitive Active GLP-1 ELISA to Confidently Measure Fasted Levels of Active GLP-1

New Ultrasensitive Active GLP-1 ELISA to Confidently Measure Fasted Levels of Active GLP-1

ALPCO has released its new STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA, the most sensitive active GLP-1 assay on the market. - November 09, 2016 - ALPCO

Viral Vectors and Plasmid DNA Manufacturing to Witness 16% Annual Growth, Predicts Roots Analysis

Roots Analysis has announced the addition of the “Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026” report to its portfolio. The report features an extensive study of the rapidly growing market of gene therapy vectors. Kashish Goel, the principal analyst, said, “Gene... - November 02, 2016 - Roots Analysis

New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories

5-year Study Tracks Central Lab Performance and Identifies Opportunities for Pharma Sponsors to Improve Clinical Investigator Satisfaction. - October 24, 2016 - Life Science Strategy Group, LLC

Presentation from electroCore Shows That Healthcare Costs for Patients with a Primary Headache Diagnosis Cost Four Times More Than a Healthy Patient Due to Comorbidities

Research presented at the Academy of Managed Care Pharmacy (AMCP) Nexus in early October in Washington, DC, showed that 60 percent of adult patients who were diagnosed with primary headache had one or more comorbidities which raised the average annual cost of their healthcare to over $20,000. This... - October 22, 2016 - electroCore

Experimentica Ltd. Appoints New Director of In Vivo Pharmacology

Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Tamuna Bolkvadze, Ph.D. to Director In Vivo Pharmacology, effective immediately. Dr. Bolkvadze joined Experimentica Ltd. earlier in 2016 as Research Scientist and has been instrumental... - October 22, 2016 - Experimentica Ltd

Nerviano Medical Sciences Presents Data Regarding a Potent New Cytotoxic Molecule for ADC Generation

NMS-P945 is a potent, innovative and proprietary cytotoxic molecule in the nms pipeline, hbighly suited to conjugation with targeted antibodies. - October 20, 2016 - NMS Group

Bioscience Americas Senior Scientific Advisor Presents at Major FDA Public Hearing

Bioscience Americas Senior Scientific Advisor Presents at Major FDA Public Hearing

Dr. Leslie Miller backs the creation of a Registry of Cell Therapy to provide guidelines for stem cell use in therapies and treatments. - October 17, 2016 - Bioscience Americas

Press Releases 501 - 550 of 2,291